Literature DB >> 19822664

Transforming potential of Src family kinases is limited by the cholesterol-enriched membrane microdomain.

Chitose Oneyama1, Takuya Iino, Kazunobu Saito, Kei Suzuki, Akira Ogawa, Masato Okada.   

Abstract

The upregulation of Src family kinases (SFKs) has been implicated in cancer progression, but the molecular mechanisms regulating their transforming potentials remain unclear. Here we show that the transforming ability of all SFK members is suppressed by being distributed to the cholesterol-enriched membrane microdomain. All SFKs could induce cell transformation when overexpressed in C-terminal Src kinase (Csk)-deficient fibroblasts. However, their transforming abilities varied depending on their affinity for the microdomain. c-Src and Blk, with a weak affinity for the microdomain due to a single myristate modification at the N terminus, could efficiently induce cell transformation, whereas SFKs with both myristate and palmitate modifications were preferentially distributed to the microdomain and required higher doses of protein expression to induce transformation. In contrast, disruption of the microdomain by depleting cholesterol could induce a robust transformation in Csk-deficient fibroblasts in which only a limited amount of activated SFKs was expressed. Conversely, the addition of cholesterol or recruitment of activated SFKs to the microdomain via a transmembrane adaptor, Cbp/PAG1, efficiently suppressed SFK-induced cell transformation. These findings suggest that the membrane microdomain spatially limits the transforming potential of SFKs by sequestering them away from the transforming pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19822664      PMCID: PMC2786866          DOI: 10.1128/MCB.00941-09

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

1.  LAB: a new membrane-associated adaptor molecule in B cell activation.

Authors:  Erin Janssen; Minghua Zhu; Weijia Zhang; Surapong Koonpaew; Weiguo Zhang
Journal:  Nat Immunol       Date:  2003-01-06       Impact factor: 25.606

2.  Molecular cloning of a novel gene encoding a membrane-associated adaptor protein (LAX) in lymphocyte signaling.

Authors:  Minghua Zhu; Erin Janssen; Kin Leung; Weiguo Zhang
Journal:  J Biol Chem       Date:  2002-09-30       Impact factor: 5.157

Review 3.  Lipid rafts and signal transduction.

Authors:  K Simons; D Toomre
Journal:  Nat Rev Mol Cell Biol       Date:  2000-10       Impact factor: 94.444

Review 4.  Transmembrane adapters: attractants for cytoplasmic effectors.

Authors:  Jonathan A Lindquist; Luca Simeoni; Burkhart Schraven
Journal:  Immunol Rev       Date:  2003-02       Impact factor: 12.988

5.  Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation.

Authors:  Tsuyoshi Akagi; Ken Sasai; Hidesaburo Hanafusa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

6.  Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.

Authors:  Thorbjørn Krejsgaard; Claudia S Vetter-Kauczok; Anders Woetmann; Hermann Kneitz; Karsten W Eriksen; Paola Lovato; Qian Zhang; Mariusz A Wasik; Carsten Geisler; Elisabeth Ralfkiaer; Juergen C Becker; Niels Ødum
Journal:  Blood       Date:  2009-04-07       Impact factor: 22.113

Review 7.  Src family kinases in tumor progression and metastasis.

Authors:  Justin M Summy; Gary E Gallick
Journal:  Cancer Metastasis Rev       Date:  2003-12       Impact factor: 9.264

8.  Non-T cell activation linker (NTAL): a transmembrane adaptor protein involved in immunoreceptor signaling.

Authors:  Tomás Brdicka; Martin Imrich; Pavla Angelisová; Nadezda Brdicková; Ondrej Horváth; Jirí Spicka; Ivan Hilgert; Petra Lusková; Petr Dráber; Petr Novák; Niklas Engels; Jürgen Wienands; Luca Simeoni; Jan Osterreicher; Enrique Aguado; Marie Malissen; Burkhart Schraven; Václav Horejsí
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

9.  Phosphoprotein associated with glycosphingolipid-enriched microdomains (PAG), a novel ubiquitously expressed transmembrane adaptor protein, binds the protein tyrosine kinase csk and is involved in regulation of T cell activation.

Authors:  T Brdicka; D Pavlistová; A Leo; E Bruyns; V Korínek; P Angelisová; J Scherer; A Shevchenko; I Hilgert; J Cerný; K Drbal; Y Kuramitsu; B Kornacker; V Horejsí; B Schraven
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

10.  LIME, a novel transmembrane adaptor protein, associates with p56lck and mediates T cell activation.

Authors:  Eun Mi Hur; Myoungsun Son; Ok-Hee Lee; Young Bong Choi; Changwon Park; Hyunsook Lee; Yungdae Yun
Journal:  J Exp Med       Date:  2003-11-10       Impact factor: 14.307

View more
  29 in total

Review 1.  Cholesterol in platelet biogenesis and activation.

Authors:  Nan Wang; Alan R Tall
Journal:  Blood       Date:  2016-02-29       Impact factor: 22.113

2.  Engineered kinase activation reveals unique morphodynamic phenotypes and associated trafficking for Src family isoforms.

Authors:  Pei-Hsuan Chu; Denis Tsygankov; Matthew E Berginski; Onur Dagliyan; Shawn M Gomez; Timothy C Elston; Andrei V Karginov; Klaus M Hahn
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-12       Impact factor: 11.205

3.  Activation of Lyn tyrosine kinase through decreased membrane cholesterol levels during a change in its membrane distribution upon cell detachment.

Authors:  Takao Morinaga; Kohei Abe; Yuji Nakayama; Noritaka Yamaguchi; Naoto Yamaguchi
Journal:  J Biol Chem       Date:  2014-08-07       Impact factor: 5.157

Review 4.  Targeting protein lipidation in disease.

Authors:  Marilyn D Resh
Journal:  Trends Mol Med       Date:  2012-02-17       Impact factor: 11.951

5.  Fer tyrosine kinase oligomer mediates and amplifies Src-induced tumor progression.

Authors:  C Oneyama; Y Yoshikawa; Y Ninomiya; T Iino; S Tsukita; M Okada
Journal:  Oncogene       Date:  2015-04-13       Impact factor: 9.867

6.  Differential transformation capacity of Src family kinases during the initiation of prostate cancer.

Authors:  Houjian Cai; Daniel A Smith; Sanaz Memarzadeh; Clifford A Lowell; Jonathan A Cooper; Owen N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

7.  Down-regulation of the tumor suppressor C-terminal Src kinase (Csk)-binding protein (Cbp)/PAG1 is mediated by epigenetic histone modifications via the mitogen-activated protein kinase (MAPK)/phosphatidylinositol 3-kinase (PI3K) pathway.

Authors:  Kei Suzuki; Chitose Oneyama; Hironobu Kimura; Shoji Tajima; Masato Okada
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

8.  C-Src and c-Yes are two unlikely partners of spermatogenesis and their roles in blood-testis barrier dynamics.

Authors:  Xiang Xiao; Dolores D Mruk; Faith L Cheng; C Yan Cheng
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

9.  Oncogenic signaling by tyrosine kinases of the SRC family in advanced colorectal cancer.

Authors:  Audrey Sirvent; Christine Benistant; Serge Roche
Journal:  Am J Cancer Res       Date:  2012-06-28       Impact factor: 6.166

10.  YES oncogenic activity is specified by its SH4 domain and regulates RAS/MAPK signaling in colon carcinoma cells.

Authors:  Fanny Dubois; Cédric Leroy; Valérie Simon; Christine Benistant; Serge Roche
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.